# QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

> **NCT00630552** · PHASE1,PHASE2 · COMPLETED · sponsor: **NantCell, Inc.** · enrollment: 138 (actual)

## Conditions studied

- Adenocarcinoma of the Pancreas
- Metastatic Pancreatic Cancer
- Pancreatic Cancer

## Interventions

- **OTHER:** Placebo
- **DRUG:** AMG 479
- **DRUG:** AMG 655

## Key facts

- **NCT ID:** NCT00630552
- **Lead sponsor:** NantCell, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-01
- **Final completion:** 2012-04
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630552, "QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00630552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*